MedWire News - Diabetes - Saxagliptin non-inferior to glipizide in Type 2 diabetes
Links shared publicly online about this topic.
- 806total visits
MedWire News - Diabetes - Saxagliptin non-inferior to glipizide in Type 2 diabetes
MedWire News For patients with Type 2 diabetes who show inadequate glycemic control on metformin alone, add-on therapy with saxagliptin achieves equivalent reductions in glycated hemoglobin as standard glipizide, results of a non-inferiority trial show. MedWire News
View full resource at medwire-news.md
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Onglyza, Glucotrol, News
Most Recently Shared on October 12, 2010 at 9:22 pm By:
Saxagliptin non-inferior to glipizide in Type 2 diabetes: For patients with Type 2 diabetes who show inadequate gl... http://bit.ly/bMxJb6
Advertisement
